Stock Events

Stock Events

Galectin Therapeutics (GALT) Q3 2023 Earnings

13NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.24

-0.21

-0.18

-0.15

Details

Expected EPS

-0.16

Actual EPS

-0.24

Surprise EPS

-0.08

Surprise Percent

+50%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.24 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.